BioSpace News Archive

Deals

Valeant Pharmaceuticals International Divests Asia Region to Invida Pharmaceutical Holdings for $37.8 Million

March 3, 2008
·
3 min read
Drug Development

Alexza Pharmaceuticals, Inc.'s AZ-104 Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache

March 3, 2008
·
10 min read
Business

MicroDose Technologies Inc Grants Global License to Merck & Co., Inc. for Use of the MicroDose Inhaler with Merck’s Proprietary Products

March 3, 2008
·
2 min read
Deals

Safeguard Scientifics Sells Stake in Six Legacy Partner Companies for $100 Million to Saints Capital

March 3, 2008
·
7 min read
Deals

AEterna Zentaris and Paladin Labs Inc. Announce Sale and Purchase of Miltefosine Rights for Cdn $9.125 M

March 3, 2008
·
4 min read
Policy

FDA Grants Priority Review for Eisai Company, Ltd.'s ACIPHEX(R) sNDA for Short-Term Treatment of GERD in Adolescents

March 3, 2008
·
2 min read
Deals

DW Healthcare Partners Announces the Sale of Tandem Labs

March 3, 2008
·
1 min read
Drug Development

FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)

March 3, 2008
·
3 min read
Drug Development

Publication in Clinical Cancer Research Confirms Ability of Peregrine Pharmaceuticals, Inc.'s Bavituximab to Target Tumor Blood Vessels with Excellent Specificity

March 3, 2008
·
6 min read
Policy

FDA Deals Blow to Vasogen’s Celacade Heart Failure Treatment

March 3, 2008
·
6 min read